Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/CLGN/Capital expenditures

CollPlant Biotechnologies Ltd (CLGN) Capital expenditures 2018–2025

CollPlant Biotechnologies Ltd (CLGN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$28,000FY2025 · since FY2018: $832,000 → $28,000
1819202122232425
Fiscal yearValueYoY
FY2025$28,000-94.2%
FY2024$483,000-49.4%
FY2023$954,000-25.1%
FY2022$1.3M-10.8%
FY2021$1.4M+226.8%
FY2020$437,000-70.7%
FY2019$1.5M+79.2%
FY2018$832,000—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More CLGN financial trends

CLGN RevenueCLGN Net incomeCLGN Net marginCLGN Gross profitCLGN Gross marginCLGN Operating incomeCLGN Operating marginCLGN Operating cash flowCLGN Free cash flowCLGN Return on equityCLGN Stock buybacksCLGN Dividends paidCLGN Total assetsCLGN Total liabilitiesCLGN Shareholders’ equityCLGN overview →